real-time news and commentary for investors
Thursday, Oct 17
Ziopharm surges, extends recent gains
- Shares of Ziopharm Oncology (ZIOP +9.9%) are trading sharply higher on the session.
- Earlier, the company announced that it, along with Intrexon (XON +0.1%), will present at the International Conference on Molecular Targets and Cancer Therapeutics this month.
- The poster presentations will highlight ZIOP's "monogenic system which enables the controlled delivery of therapeutic interleukin-12, in a brain tumor model," as well as other pipeline programs. (PR)
- With today's gains, the shares are up ~52% since September 27, when the company presented at the Biotech Industry Conference in New York.